# Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

> **NCT04492618** · PHASE2 · COMPLETED · sponsor: **Aaron R. Mangold** · enrollment: 12 (actual)

## Conditions studied

- Necrobiosis Lipoidica

## Interventions

- **DRUG:** Ruxolitinib

## Key facts

- **NCT ID:** NCT04492618
- **Lead sponsor:** Aaron R. Mangold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2022-03-16
- **Final completion:** 2022-03-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04492618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04492618, "Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04492618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*